Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
JD HEALTH
06618
5
ALI HEALTH
00241
| (Q9)Sep 30, 2025 | (Q6)Jun 30, 2025 | (Q1)Mar 31, 2025 | (FY)Dec 31, 2024 | (Q9)Sep 30, 2024 | (Q6)Jun 30, 2024 | (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q9)Sep 30, 2023 | (Q6)Jun 30, 2023 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Special items of operating revenue | 21.96%10.23B | 17.67%7.48B | 11.05%3.23B | -3.92%14.2B | -17.83%8.39B | -25.25%6.36B | -18.10%2.91B | -1.63%14.78B | -10.21%10.21B | 13.22%8.51B |
| Operating income | 21.96%10.23B | 17.67%7.48B | 11.05%3.23B | -3.92%14.2B | -17.83%8.39B | -25.25%6.36B | -18.10%2.91B | -1.63%14.78B | -10.21%10.21B | 13.22%8.51B |
| Operating expenses | ||||||||||
| Gross profit | ||||||||||
| Administrative expenses | -17.70%-4.7B | ---- | -10.44%-1.47B | ---- | 12.59%-4B | ---- | 11.11%-1.33B | ---- | -16.79%-4.57B | ---- |
| Employee expense | ---- | -19.66%-2.02B | ---- | 9.70%-3.83B | ---- | 19.00%-1.69B | ---- | -5.19%-4.24B | ---- | -14.83%-2.08B |
| Depreciation and amortization | ---- | 0.66%-328.22M | ---- | 0.39%-672.49M | ---- | 0.75%-330.39M | ---- | -10.12%-675.11M | ---- | -11.46%-332.9M |
| Impairment and provision | -3,631.02%-112.37M | -274.62%-59.52M | 1,108.49%16.63M | 100.16%1.08M | 98.52%-3.01M | 225.92%34.09M | -116.39%-1.65M | -1,949.67%-668.57M | -276.05%-203.62M | -126.10%-27.07M |
| -Other impairment is provision | -3,631.02%-112.37M | -274.62%-59.52M | 1,108.49%16.63M | 100.16%1.08M | 98.52%-3.01M | 225.92%34.09M | -116.39%-1.65M | -1,949.67%-668.57M | -276.05%-203.62M | -126.10%-27.07M |
| Operating interest expense | -2.98%-2.04B | -1.47%-1.39B | -2.92%-724.19M | 17.32%-2.7B | 19.23%-1.98B | 17.31%-1.37B | 12.06%-703.63M | -0.60%-3.27B | -0.30%-2.45B | -1.04%-1.66B |
| Special items of operating profit | 56.68%-23.67M | -12.05%-1.66B | 56.57%-7.66M | -187.75%-3.47B | 80.63%-54.65M | 11.42%-1.48B | 47.83%-17.63M | 63.96%-1.21B | 64.12%-282.17M | -41.78%-1.67B |
| Operating profit | 41.95%3.3B | 32.65%2B | 21.70%1.03B | -25.61%3.47B | -12.42%2.32B | -44.36%1.51B | -30.49%845.63M | 24.28%4.66B | -38.07%2.65B | 2.15%2.71B |
| Share of profits of associates | ---- | -35.73%43.01M | ---- | 17.01%114.99M | ---- | 1.30%66.92M | ---- | -6.54%98.28M | ---- | 0.24%66.06M |
| Adjustment items of earning before tax | 69.58%-7.12M | ---- | 119.55%1.08M | ---- | -101.09%-23.41M | ---- | -494.09%-5.54M | ---- | 26,467.97%2.15B | ---- |
| Earning before tax | 43.09%3.29B | 29.74%2.04B | 22.63%1.03B | -24.73%3.58B | -52.06%2.3B | -43.27%1.57B | -30.89%840.09M | 23.44%4.76B | 12.21%4.8B | 2.10%2.77B |
| Tax | -100.03%-586.39M | -104.40%-344.18M | -35.92%-206.04M | -8.44%-495.23M | 29.22%-293.16M | 52.40%-168.39M | 38.23%-151.59M | 25.53%-456.69M | 49.66%-414.21M | 38.15%-353.75M |
| After-tax profit from continuing operations | 34.77%2.71B | 20.79%1.7B | 19.71%824.19M | -28.25%3.09B | -54.22%2.01B | -41.94%1.4B | -29.04%688.5M | 32.71%4.3B | 26.95%4.39B | 12.85%2.42B |
| Earning after tax | 34.77%2.71B | 20.79%1.7B | 19.71%824.19M | -28.25%3.09B | -54.22%2.01B | -41.94%1.4B | -29.04%688.5M | 32.71%4.3B | 26.95%4.39B | 12.85%2.42B |
| Minority profit | 60.95%27.61M | -4.41%12.79M | -18.66%4.93M | -7.64%27.2M | -37.12%17.15M | -48.53%13.38M | -51.49%6.06M | -42.87%29.45M | -43.43%27.28M | -26.12%26M |
| Profit attributable to shareholders | 34.55%2.68B | 21.03%1.68B | 20.05%819.26M | -28.39%3.06B | -54.33%1.99B | -41.87%1.39B | -28.75%682.44M | 33.93%4.27B | 27.95%4.36B | 13.50%2.39B |
| Basic earnings per share | 40.54%0.52 | 23.08%0.32 | 23.08%0.16 | -30.95%0.58 | -57.95%0.37 | -45.83%0.26 | -31.58%0.13 | 37.70%0.84 | 29.41%0.88 | 14.29%0.48 |
| Diluted earnings per share | 40.54%0.52 | 23.08%0.32 | 23.08%0.16 | -30.95%0.58 | -57.95%0.37 | -45.83%0.26 | -31.58%0.13 | 37.70%0.84 | 29.41%0.88 | 14.29%0.48 |
| Currency Unit | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY |
| Accounting Standards | CAS (2007) | IAS | CAS (2007) | IAS | CAS (2007) | IAS | CAS (2007) | IAS | CAS (2007) | IAS |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.